-- Hyperpigmentation Disorder Treatment Market Overview
Hyperpigmentation disorders are skin conditions identified by darkened skin areas. The types include melasma, post-inflammatory hyperpigmentation, and age spots. Hyperpigmentation takes place when the skin creates more melanin. This can cause patches or spots of skin look darker than surrounding areas. It is usually harmless but can often be triggered by a fundamental medical condition. Certain medications can also cause skin darkening.
In 2017, the hyperpigmentation disorders treatment was projected to generate a market value of USD 3,915 million globally. It is likely to develop at a CAGR of 7.1% over the forecast period.
Expanding need for minimally invasive dermabrasion methods are encouraging the adoption of lasers. Besides, expenditures on cosmetics are increasing rapidly. These factors are expected to drive the development of the hyperpigmentation disorders treatment market.
Ask for a Free Sample copy at https://www.marketresearchfuture.com/sample_request/7462
Additionally, effective tactics devised by market leaders collectively with investments in research and development is accelerating the market to an extent. The number of dermabrasion cosmetic methods have soared from 42,218 in 2000 to 88,182 in 2016, as stated by American Society of Plastic Surgeons. This phenomenon was identified with a 109% surge over the forecast period. However, expensive treatments along with inadequate reimbursement policy is estimated to restraint the market.
Key Players
The global hyperpigmentation disorders treatment market is driven by key players such as
Bayer AG
Allergan Inc.
Episciences Inc.
EpiPharm AG
Obagi Cosmeceuticals LLC
Galderma laboratories (Nestle Skin Health S.A)
RXi Pharmaceuticals Corporation
Pierre Fabre
Vivier Pharma
and SkinCeuticals International.
Market Segmentation
The worldwide hyperpigmentation disorders treatment market has been segmented based on disease indication, treatment type, and end-user.
Based on disease indication, the hyperpigmentation disorders treatment market has been segmented into melasma, solar lentigines, post-inflammatory hyperpigmentation, and others.
Based on treatment type, the market has been segmented as microdermabrasion, topical drugs, chemical peels, phototherapy, laser therapy, and others. Over the forecast period, the topical drugs segment is likely to hold a major market share for the hyperpigmentation disorders treatment.
Based on end-user, the market has been segmented into aesthetic clinics, dermatology centers, hospitals, and others.
Access Detailed Report Page Along with List of Figures and List of Tables on https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462
Regional Analysis
Asia-Pacific market is likely to lead the worldwide hyperpigmentation disorders treatment market attributing to the increasing awareness about hyperpigmentation ailments, advanced healthcare technology, increased healthcare spending, and vast patient population. Furthermore, Asia-Pacific is also anticipated to be the fastest-growing hyperpigmentation disorders treatment market over the forecast period. The world bank group recorded that in 2014, China disbursed 4.96% of gross domestic product (GDP) in healthcare outlay. However, healthcare expenditure reached 5.32% of GDP by 2015. Correspondingly, in 2014, India expended 3.63% of GDP on healthcare and in 2015, healthcare expenditure reached up to 3.89% of GDP.
The Americas market is likely to be the second-largest hyperpigmentation disorders treatment market. The growth in the Americas is owing to government investments and support of the healthcare sector collectively with expanding research and development. Plus, promising reimbursement tactics in American nations are contributing to the progress of the market in this region.
Europe represents the third largest hyperpigmentation disorders treatment market over the forecast period. The growth is owing to the geriatric population. Additionally, the government of these nations are more focused to offer the best treatment choices to their residents. As per the report issued by World Health Organization, in 2016, the aging population in Europe will rise from 14 million to 19 million in 2020. In 2050, it will rise further up to 40 million.
Avail an Exclusive Discount at https://www.marketresearchfuture.com/check-discount/7462
Intended Audience
Medical devices manufacturers
Pharmaceutical Companies
Medical devices product distributors and suppliers
Healthcare providers
Research institutes and academic centers
Government associations
Market research and consulting
The Middle East & Africa is likely to witness the least growth in the global hyperpigmentation disorders treatment market owing to lack of technical knowledge and underdeveloped medical services. However, diseases such as Dermatosis Papulosa Nigra (DPN) is commonly found in Afro-Caribbean, sub-Saharan African and African American patients. Additionally, Actinic lichen planus is a rare skin condition that is mostly found in residents of the Middle Eastern nations. These trends offer a potential market for the global players.
About Market Research Future: Our team have supreme objective to provide the optimum quality market research and intelligence services to our clients. market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Email: [email protected]
Contact Info:
Name: Mr. Akash Anand.
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune.
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/hyperpigmentation-disorders-treatment-market-7462
Release ID: 526092
Google
RSS